Skip to main content
Clinical Trials/NCT03740438
NCT03740438
Completed
Not Applicable

Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course

Hospital Clinic of Barcelona1 site in 1 country154 target enrollmentSeptember 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Surgical Blood Loss
Sponsor
Hospital Clinic of Barcelona
Enrollment
154
Locations
1
Primary Endpoint
Hemoglobin concentration
Status
Completed
Last Updated
last year

Overview

Brief Summary

transfusion-related decisions in the perioperative setting are often complex due to acute variations in the hemoglobin levels, which typically experience a progressive decrease within days. This process, commonly referred to as "hemoglobin drop" or "hemoglobin drift", has been observed to be highly variable among patients and reliant on several variables, such as the volemic status, fluid balance and blood loss. Although it has been investigated and some predictors have been identified, postoperative hemoglobin drop remains unpredictable and is not fully clarified. In consequence, hemoglobin levels' variations are frequently misunderstood, hindering the decision to transfuse.

Registry
clinicaltrials.gov
Start Date
September 1, 2018
End Date
September 2, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sebastian Jaramillo

Principal Investigator

Hospital Clinic of Barcelona

Eligibility Criteria

Inclusion Criteria

  • Adult patients electively scheduled for laparoscopic urologic and gynecologic surgery.

Exclusion Criteria

  • Suspected or confirmed coagulopathy (including current treatment with anticoagulants or antiplatelet agents).
  • Requirement for surgical gauzes during surgery, including conversion to open surgical techniques.
  • Transfusion of red blood cells (RBCs) or use of blood recovery systems during the perioperative period.
  • Significant postoperative bleeding (\> 50 ml in surgical drains, gross hematuria, or any other type of significant blood loss).
  • Postoperative hemodynamic instability (defined as requirement of vasoactive drugs).
  • Other major postoperative complications during the observable period.

Outcomes

Primary Outcomes

Hemoglobin concentration

Time Frame: 2-5 days

Patient´s hemoglobin concentration in the postoperative course (measured every 24 hours)

Study Sites (1)

Loading locations...

Similar Trials